{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T03:14:51Z","timestamp":1794280491855,"version":"4.9.0"},"reference-count":103,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100015595","name":"GHR Foundation","doi-asserted-by":"publisher","award":["UC7AI094660"],"award-info":[{"award-number":["UC7AI094660"]}],"id":[{"id":"10.13039\/100015595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Gates Foundation","doi-asserted-by":"publisher","award":["INV-001650"],"award-info":[{"award-number":["INV-001650"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016302","name":"Coalition for Epidemic Preparedness Innovations","doi-asserted-by":"publisher","award":["PRJ-6111"],"award-info":[{"award-number":["PRJ-6111"]}],"id":[{"id":"10.13039\/100016302","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institutes of Health National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["UC7AI094660"],"award-info":[{"award-number":["UC7AI094660"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institutes of Health National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI125179"],"award-info":[{"award-number":["AI125179"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007875","name":"Tulane University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007875","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000861","name":"Burroughs Wellcome Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000861","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011094","name":"Public Health Agency of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011094","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.ebiom.2025.105647","type":"journal-article","created":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T01:05:31Z","timestamp":1743469531000},"page":"105647","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Preclinical development of a replication-competent vesicular stomatitis virus-based Lassa virus vaccine candidate advanced into human clinical trials"],"prefix":"10.1016","volume":"114","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5211-6502","authenticated-orcid":false,"given":"Christopher L.","family":"Cooper","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5436-1993","authenticated-orcid":false,"given":"Gavin","family":"Morrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maoli","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3558-9084","authenticated-orcid":false,"given":"Thomas S.","family":"Postler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxwell L.","family":"Neal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert W.","family":"Cross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney","family":"Woolsey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krystle N.","family":"Agans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktoriya","family":"Borisevich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan P.","family":"McNamara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Atyeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicky","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daritza","family":"Germosen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuxiang","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shui L.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Reiserova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yesle","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Wallace-Selman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexei","family":"Carpov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuqiang","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah J.","family":"Frederick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"DeStefano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne M.","family":"Ercolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8225-6688","authenticated-orcid":false,"given":"Adrian S.","family":"Enriquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn M.","family":"Hastie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzane","family":"Ramos da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eddy","family":"Sayeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John W.","family":"Coleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2350-0142","authenticated-orcid":false,"given":"Andrew","family":"Kilianski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Galit","family":"Alter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica Ollmann","family":"Saphire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"Aitchison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas W.","family":"Geisbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swati B.","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark B.","family":"Feinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2066-4483","authenticated-orcid":false,"given":"Christopher L.","family":"Parks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ebiom.2025.105647_bib1","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/s41579-022-00789-8","article-title":"Lassa fever - the road ahead","volume":"21","author":"Garry","year":"2023","journal-title":"Nat Rev Microbiol"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105647_bib2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1008811","article-title":"Bridging the gap: using reservoir ecology and human serosurveys to estimate Lassa virus spillover in West Africa","volume":"17","author":"Basinski","year":"2021","journal-title":"PLoS Comput Biol"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105647_bib3","doi-asserted-by":"crossref","first-page":"5596","DOI":"10.1038\/s41467-022-33112-3","article-title":"Predicting the evolution of the Lassa virus endemic area and population at risk over the next decades","volume":"13","author":"Klitting","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.ebiom.2025.105647_bib4","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ijid.2022.04.004","article-title":"Lassa virus infection: a summary for clinicians","volume":"119","author":"Raabe","year":"2022","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ebiom.2025.105647_bib5","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.antiviral.2018.09.009","article-title":"The WHO R&D Blueprint: 2018 review of emerging infectious diseases requiring urgent research and development efforts","volume":"159","author":"Mehand","year":"2018","journal-title":"Antiviral Res"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105647_bib6","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/nri.2016.138","article-title":"Immunobiology of Ebola and lassa virus infections","volume":"17","author":"Prescott","year":"2017","journal-title":"Nat Rev Immunol"},{"issue":"10","key":"10.1016\/j.ebiom.2025.105647_bib7","article-title":"Understanding immune responses to lassa virus infection and to its candidate vaccines","volume":"10","author":"Murphy","year":"2022","journal-title":"Vaccines (Basel)"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105647_bib8","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s42003-020-01543-7","article-title":"Systemic viral spreading and defective host responses are associated with fatal Lassa fever in macaques","volume":"4","author":"Baillet","year":"2021","journal-title":"Commun Biol"},{"issue":"11","key":"10.1016\/j.ebiom.2025.105647_bib9","doi-asserted-by":"crossref","first-page":"5890","DOI":"10.1128\/JVI.01948-08","article-title":"Early and strong immune responses are associated with control of viral replication and recovery in lassa virus-infected cynomolgus monkeys","volume":"83","author":"Baize","year":"2009","journal-title":"J\u00a0Virol"},{"issue":"34","key":"10.1016\/j.ebiom.2025.105647_bib10","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2304876120","article-title":"A\u00a0human monoclonal antibody combination rescues nonhuman primates from advanced disease caused by the major lineages of Lassa virus","volume":"120","author":"Cross","year":"2023","journal-title":"Proc Natl Acad Sci USA"},{"issue":"10","key":"10.1016\/j.ebiom.2025.105647_bib11","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1038\/nm.4396","article-title":"Human-monoclonal-antibody therapy protects nonhuman primates against advanced Lassa fever","volume":"23","author":"Mire","year":"2017","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.ebiom.2025.105647_bib12","article-title":"Monoclonal antibody therapy protects nonhuman primates against mucosal exposure to Lassa virus","volume":"5","author":"Cross","year":"2024","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.ebiom.2025.105647_bib13","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.coviro.2019.07.006","article-title":"A\u00a0review of Lassa fever vaccine candidates","volume":"37","author":"Salami","year":"2019","journal-title":"Curr Opin Virol"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105647_bib14","article-title":"Vaccine candidates against arenavirus infections","volume":"11","author":"Saito","year":"2023","journal-title":"Vaccines (Basel)"},{"issue":"6","key":"10.1016\/j.ebiom.2025.105647_bib15","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/tmi.13876","article-title":"Lassa fever vaccine candidates: a scoping review of vaccine clinical trials","volume":"28","author":"Sulis","year":"2023","journal-title":"Trop Med Int Health"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105647_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jmv.1890370102","article-title":"Inactivated Lassa virus elicits a non protective immune response in rhesus monkeys","volume":"37","author":"McCormick","year":"1992","journal-title":"J\u00a0Med Virol"},{"issue":"6341","key":"10.1016\/j.ebiom.2025.105647_bib17","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1126\/science.aam7260","article-title":"Structural basis for antibody-mediated neutralization of Lassa virus","volume":"356","author":"Hastie","year":"2017","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105647_bib18","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/s41467-023-44534-y","article-title":"Cleavage-intermediate Lassa virus trimer elicits neutralizing responses, identifies neutralizing nanobodies, and reveals an apex-situated site-of-vulnerability","volume":"15","author":"Gorman","year":"2024","journal-title":"Nat Commun"},{"issue":"5","key":"10.1016\/j.ebiom.2025.105647_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112524","article-title":"Structural conservation of Lassa virus glycoproteins and recognition by neutralizing antibodies","volume":"42","author":"Perrett","year":"2023","journal-title":"Cell Rep"},{"issue":"7899","key":"10.1016\/j.ebiom.2025.105647_bib20","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/s41586-022-04429-2","article-title":"Structure and receptor recognition by the Lassa virus spike complex","volume":"603","author":"Katz","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2025.105647_bib21","first-page":"1","article-title":"Successful vaccines","volume":"428","author":"Amanna","year":"2020","journal-title":"Curr Top Microbiol Immunol"},{"issue":"8","key":"10.1016\/j.ebiom.2025.105647_bib22","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/s00705-023-05834-2","article-title":"Renaming of genera Ebolavirus and Marburgvirus to Orthoebolavirus and Orthomarburgvirus, respectively, and introduction of binomial species names within family Filoviridae","volume":"168","author":"Biedenkopf","year":"2023","journal-title":"Arch Virol"},{"issue":"7","key":"10.1016\/j.ebiom.2025.105647_bib23","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/nm1258","article-title":"Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses","volume":"11","author":"Jones","year":"2005","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105647_bib24","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3390\/vaccines9030190","article-title":"Development of pandemic vaccines: ERVEBO case study","volume":"9","author":"Wolf","year":"2021","journal-title":"Vaccines (Basel)"},{"issue":"10","key":"10.1016\/j.ebiom.2025.105647_bib25","doi-asserted-by":"crossref","first-page":"5458","DOI":"10.1128\/JVI.78.10.5458-5465.2004","article-title":"Properties of replication-competent vesicular stomatitis virus vectors expressing glycoproteins of filoviruses and arenaviruses","volume":"78","author":"Garbutt","year":"2004","journal-title":"J\u00a0Virol"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105647_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001567","article-title":"Recombinant vesicular stomatitis virus vaccine vectors expressing filovirus glycoproteins lack neurovirulence in nonhuman primates","volume":"6","author":"Mire","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.ebiom.2025.105647_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.jvacx.2019.100009","article-title":"rVSVDeltaG-ZEBOV-GP (also designated V920) recombinant vesicular stomatitis virus pseudotyped with Ebola Zaire Glycoprotein: standardized template with key considerations for a risk\/benefit assessment","volume":"1","author":"Monath","year":"2019","journal-title":"Vaccine X"},{"issue":"10","key":"10.1016\/j.ebiom.2025.105647_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms8101473","article-title":"To B or not to B: mechanisms of protection conferred by rVSV-EBOV-GP and the roles of innate and adaptive immunity","volume":"8","author":"Pinski","year":"2020","journal-title":"Microorganisms"},{"issue":"10068","key":"10.1016\/j.ebiom.2025.105647_bib29","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0140-6736(16)32621-6","article-title":"Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ca Suffit!)","volume":"389","author":"Henao-Restrepo","year":"2017","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ebiom.2025.105647_bib30","doi-asserted-by":"crossref","first-page":"e70","DOI":"10.1016\/S2666-5247(20)30198-1","article-title":"Estimation of the correlates of protection of the rVSVDeltaG-ZEBOV-GP Zaire ebolavirus vaccine: a post-hoc analysis of data from phase 2\/3 clinical trials","volume":"2","author":"Grais","year":"2021","journal-title":"Lancet Microbe"},{"issue":"4","key":"10.1016\/j.ebiom.2025.105647_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003736","article-title":"A\u00a0recombinant vesicular stomatitis virus-based Lassa fever vaccine protects Guinea pigs and macaques against challenge with geographically and genetically distinct Lassa viruses","volume":"9","author":"Safronetz","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"issue":"2","key":"10.1016\/j.ebiom.2025.105647_bib32","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3201\/eid2102.141649","article-title":"Vesicular stomatitis virus-based vaccines against Lassa and Ebola viruses","volume":"21","author":"Marzi","year":"2015","journal-title":"Emerg Infect Dis"},{"issue":"6","key":"10.1016\/j.ebiom.2025.105647_bib33","doi-asserted-by":"crossref","first-page":"e183","DOI":"10.1371\/journal.pmed.0020183","article-title":"Development of a new vaccine for the prevention of Lassa fever","volume":"2","author":"Geisbert","year":"2005","journal-title":"PLoS medicine"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105647_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111094","article-title":"A\u00a0recombinant VSV-vectored vaccine rapidly protects nonhuman primates against heterologous lethal Lassa fever","volume":"40","author":"Cross","year":"2022","journal-title":"Cell Rep"},{"issue":"2","key":"10.1016\/j.ebiom.2025.105647_bib35","article-title":"Human transcriptomic response to the VSV-vectored Ebola vaccine","volume":"9","author":"Santoro","year":"2021","journal-title":"Vaccines (Basel)"},{"issue":"2","key":"10.1016\/j.ebiom.2025.105647_bib36","doi-asserted-by":"crossref","first-page":"e113","DOI":"10.1016\/S2666-5247(21)00235-4","article-title":"Transcriptomic signatures induced by the Ebola virus vaccine rVSVDeltaG-ZEBOV-GP in adult cohorts in Europe, Africa, and North America: a molecular biomarker study","volume":"3","author":"Vianello","year":"2022","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.ebiom.2025.105647_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104203","article-title":"Preclinical immunogenicity and efficacy of a candidate COVID-19 vaccine based on a vesicular stomatitis virus-SARS-CoV-2 chimera","volume":"82","author":"Espeseth","year":"2022","journal-title":"EBioMedicine"},{"issue":"10","key":"10.1016\/j.ebiom.2025.105647_bib38","article-title":"Nonhuman primates are protected against Marburg virus disease by vaccination with a vesicular stomatitis virus vector-based vaccine prepared under conditions to allow advancement to human clinical trials","volume":"10","author":"Cooper","year":"2022","journal-title":"Vaccines (Basel)"},{"issue":"9","key":"10.1016\/j.ebiom.2025.105647_bib39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0106597","article-title":"A\u00a0novel, live-attenuated vesicular stomatitis virus vector displaying conformationally intact, functional HIV-1 envelope trimers that elicits potent cellular and humoral responses in mice","volume":"9","author":"Rabinovich","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ebiom.2025.105647_bib40","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms11544","article-title":"Most neutralizing human monoclonal antibodies target novel epitopes requiring both Lassa virus glycoprotein subunits","volume":"7","author":"Robinson","year":"2016","journal-title":"Nat Commun"},{"issue":"7365","key":"10.1016\/j.ebiom.2025.105647_bib41","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/nature10373","article-title":"Broad neutralization coverage of HIV by multiple highly potent antibodies","volume":"477","author":"Walker","year":"2011","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.ebiom.2025.105647_bib42","doi-asserted-by":"crossref","first-page":"4387","DOI":"10.1128\/jvi.62.11.4387-4392.1988","article-title":"Vesicular stomatitis virus M protein in the nuclei of infected cells","volume":"62","author":"Lyles","year":"1988","journal-title":"J\u00a0Virol"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105647_bib43","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nmeth.4169","article-title":"cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination","volume":"14","author":"Punjani","year":"2017","journal-title":"Nat Methods"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105647_bib44","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/pro.3943","article-title":"UCSF ChimeraX: structure visualization for researchers, educators, and developers","volume":"30","author":"Pettersen","year":"2021","journal-title":"Protein Sci"},{"issue":"12","key":"10.1016\/j.ebiom.2025.105647_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0014330","article-title":"Equivalence of ELISpot assays demonstrated between major HIV network laboratories","volume":"5","author":"Gill","year":"2010","journal-title":"PLoS One"},{"issue":"602","key":"10.1016\/j.ebiom.2025.105647_bib46","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abg6128","article-title":"Ebola vaccine-induced protection in nonhuman primates correlates with antibody specificity and Fc-mediated effects","volume":"13","author":"Meyer","year":"2021","journal-title":"Sci Transl Med"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105647_bib47","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/s41591-021-01263-3","article-title":"Humoral signatures of protective and pathological SARS-CoV-2 infection in children","volume":"27","author":"Bartsch","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.ebiom.2025.105647_bib48","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jim.2017.01.010","article-title":"Multiplexed Fc array for evaluation of antigen-specific antibody effector profiles","volume":"443","author":"Brown","year":"2017","journal-title":"J\u00a0Immunol Methods"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105647_bib49","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"issue":"7","key":"10.1016\/j.ebiom.2025.105647_bib50","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","article-title":"featureCounts: an efficient general purpose program for assigning sequence reads to genomic features","volume":"30","author":"Liao","year":"2014","journal-title":"Bioinformatics"},{"issue":"12","key":"10.1016\/j.ebiom.2025.105647_bib51","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"key":"10.1016\/j.ebiom.2025.105647_bib52","article-title":"tmod: an R package for general and multivariate enrichment analysis","volume":"4","author":"Weiner","year":"2016","journal-title":"PeerJ Preprints"},{"issue":"6","key":"10.1016\/j.ebiom.2025.105647_bib53","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The Molecular Signatures Database (MSigDB) hallmark gene set collection","volume":"1","author":"Liberzon","year":"2015","journal-title":"Cell Syst"},{"issue":"4","key":"10.1016\/j.ebiom.2025.105647_bib54","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.molcel.2010.05.004","article-title":"Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities","volume":"38","author":"Heinz","year":"2010","journal-title":"Mol Cell"},{"issue":"D1","key":"10.1016\/j.ebiom.2025.105647_bib55","doi-asserted-by":"crossref","first-page":"D607","DOI":"10.1093\/nar\/gky1131","article-title":"STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets","volume":"47","author":"Szklarczyk","year":"2019","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105647_bib56","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1080\/00401706.1964.10490181","article-title":"Multiple comparisons using rank sums","volume":"6","author":"Dunn","year":"1964","journal-title":"Technometrics"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105647_bib57","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J\u00a0R Stat Soc B (Methodological)"},{"issue":"2","key":"10.1016\/j.ebiom.2025.105647_bib58","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0167-4781(02)00462-1","article-title":"Transcriptional control of the RNA-dependent RNA polymerase of vesicular stomatitis virus","volume":"1577","author":"Barr","year":"2002","journal-title":"Biochim Biophys Acta"},{"issue":"37","key":"10.1016\/j.ebiom.2025.105647_bib59","doi-asserted-by":"crossref","first-page":"5529","DOI":"10.1016\/j.vaccine.2022.08.006","article-title":"Functional profiling of Covid 19 vaccine candidate by flow virometry","volume":"40","author":"Prout","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.ebiom.2025.105647_bib60","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/1743-422X-8-205","article-title":"Pathogenesis of Lassa fever in cynomolgus macaques","volume":"8","author":"Hensley","year":"2011","journal-title":"Virol J"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105647_bib61","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens9030197","article-title":"Animal models of lassa fever","volume":"9","author":"Sattler","year":"2020","journal-title":"Pathogens"},{"issue":"8","key":"10.1016\/j.ebiom.2025.105647_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110841","article-title":"Delineating the mechanism of anti-Lassa virus GPC-A neutralizing antibodies","volume":"39","author":"Enriquez","year":"2022","journal-title":"Cell Rep"},{"issue":"11","key":"10.1016\/j.ebiom.2025.105647_bib63","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nri2868","article-title":"Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns","volume":"10","author":"Bachmann","year":"2010","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"10.1016\/j.ebiom.2025.105647_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112402","article-title":"Antibodies against the Ebola virus soluble glycoprotein are associated with long-term vaccine-mediated protection of non-human primates","volume":"42","author":"Gunn","year":"2023","journal-title":"Cell Rep"},{"issue":"4","key":"10.1016\/j.ebiom.2025.105647_bib65","article-title":"Anamnestic humoral correlates of immunity across SARS-CoV-2 variants of concern","volume":"14","author":"McNamara","year":"2023","journal-title":"mBio"},{"issue":"11","key":"10.1016\/j.ebiom.2025.105647_bib66","doi-asserted-by":"crossref","first-page":"4328","DOI":"10.1080\/21645515.2021.1976580","article-title":"Building a better antibody through the Fc: advances and challenges in harnessing antibody Fc effector functions for antiviral protection","volume":"17","author":"Gunn","year":"2021","journal-title":"Hum Vaccines Immunother"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105647_bib67","doi-asserted-by":"crossref","first-page":"4174","DOI":"10.1038\/s41467-023-39189-8","article-title":"Waning and boosting of antibody Fc-effector functions upon SARS-CoV-2 vaccination","volume":"14","author":"Tong","year":"2023","journal-title":"Nat Commun"},{"issue":"5","key":"10.1016\/j.ebiom.2025.105647_bib68","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/COH.0000000000000644","article-title":"Roles of fragment crystallizable-mediated effector functions in broadly neutralizing antibody activity against HIV","volume":"15","author":"Danesh","year":"2020","journal-title":"Curr Opin HIV AIDS"},{"issue":"11","key":"10.1016\/j.ebiom.2025.105647_bib69","doi-asserted-by":"crossref","first-page":"e696","DOI":"10.1016\/S1473-3099(24)00229-9","article-title":"Lassa fever research priorities: towards effective medical countermeasures by the end of the decade","volume":"24","author":"Moore","year":"2024","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"10.1016\/j.ebiom.2025.105647_bib70","article-title":"Hybrid immunity expands the functional humoral footprint of both mRNA and vector-based SARS-CoV-2 vaccines","volume":"4","author":"Kaplonek","year":"2023","journal-title":"Cell Rep Med"},{"issue":"4","key":"10.1016\/j.ebiom.2025.105647_bib71","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/ni.3123","article-title":"Control of adaptive immunity by the innate immune system","volume":"16","author":"Iwasaki","year":"2015","journal-title":"Nat Immunol"},{"issue":"9","key":"10.1016\/j.ebiom.2025.105647_bib72","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1016\/j.celrep.2017.08.023","article-title":"Systems vaccinology identifies an early innate immune signature as a correlate of antibody responses to the Ebola vaccine rVSV-ZEBOV","volume":"20","author":"Rechtien","year":"2017","journal-title":"Cell Rep"},{"issue":"2","key":"10.1016\/j.ebiom.2025.105647_bib73","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/ni.2789","article-title":"Molecular signatures of antibody responses derived from a systems biology study of five human vaccines","volume":"15","author":"Li","year":"2014","journal-title":"Nat Immunol"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105647_bib74","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.immuni.2008.05.012","article-title":"A\u00a0modular analysis framework for blood genomics studies: application to systemic lupus erythematosus","volume":"29","author":"Chaussabel","year":"2008","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105647_bib75","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1172\/JCI131958","article-title":"Quadrivalent VesiculoVax vaccine protects nonhuman primates from viral-induced hemorrhagic fever and death","volume":"130","author":"Cross","year":"2020","journal-title":"J\u00a0Clin Invest"},{"issue":"5512","key":"10.1016\/j.ebiom.2025.105647_bib76","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1126\/science.1058867","article-title":"Preferential localization of effector memory cells in nonlymphoid tissue","volume":"291","author":"Masopust","year":"2001","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105647_bib77","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nri1783","article-title":"Antiviral antibody responses: the two extremes of a wide spectrum","volume":"6","author":"Hangartner","year":"2006","journal-title":"Nat Rev Immunol"},{"issue":"16","key":"10.1016\/j.ebiom.2025.105647_bib78","doi-asserted-by":"crossref","first-page":"8293","DOI":"10.1128\/JVI.02120-10","article-title":"Human dendritic cells infected with the nonpathogenic Mopeia virus induce stronger T-cell responses than those infected with Lassa virus","volume":"85","author":"Pannetier","year":"2011","journal-title":"J\u00a0Virol"},{"issue":"5","key":"10.1016\/j.ebiom.2025.105647_bib79","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.4049\/jimmunol.172.5.2861","article-title":"Lassa virus infection of human dendritic cells and macrophages is productive but fails to activate cells","volume":"172","author":"Baize","year":"2004","journal-title":"J\u00a0Immunol"},{"issue":"6","key":"10.1016\/j.ebiom.2025.105647_bib80","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.4049\/jimmunol.170.6.2797","article-title":"Cutting edge: impairment of dendritic cells and adaptive immunity by Ebola and Lassa viruses","volume":"170","author":"Mahanty","year":"2003","journal-title":"J\u00a0Immunol"},{"issue":"11","key":"10.1016\/j.ebiom.2025.105647_bib81","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007430","article-title":"Lassa virus activates myeloid dendritic cells but suppresses their ability to stimulate T cells","volume":"14","author":"Schaeffer","year":"2018","journal-title":"PLoS Pathog"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105647_bib82","article-title":"Usp18 expression in CD169(+) macrophages is important for strong immune response after vaccination with VSV-EBOV","volume":"8","author":"Friedrich","year":"2020","journal-title":"Vaccines (Basel)"},{"issue":"2","key":"10.1016\/j.ebiom.2025.105647_bib83","first-page":"131","article-title":"Immune consequences of in\u00a0vitro infection of human peripheral blood leukocytes with\u00a0vesicular stomatitis virus","volume":"10","author":"Tomczyk","year":"2018","journal-title":"J\u00a0Innate Immun"},{"issue":"8","key":"10.1016\/j.ebiom.2025.105647_bib84","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1038\/mt.2009.95","article-title":"Recombinant vesicular stomatitis virus transduction of dendritic cells enhances their ability to prime innate and adaptive antitumor immunity","volume":"17","author":"Boudreau","year":"2009","journal-title":"Mol Ther"},{"issue":"6","key":"10.1016\/j.ebiom.2025.105647_bib85","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1354\/vp.43-6-943","article-title":"Experimental vesicular stomatitis virus infection in horses: effect of route of inoculation and virus serotype","volume":"43","author":"Howerth","year":"2006","journal-title":"Vet Pathol"},{"issue":"8","key":"10.1016\/j.ebiom.2025.105647_bib86","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/j.vaccine.2023.01.059","article-title":"Cellular and humoral immunity to Ebola Zaire glycoprotein and viral vector proteins following immunization with recombinant vesicular stomatitis virus-based Ebola vaccine (rVSVDeltaG-ZEBOV-GP)","volume":"41","author":"Raabe","year":"2023","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.ebiom.2025.105647_bib87","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1093\/infdis\/jiy565","article-title":"Detectable vesicular stomatitis virus (VSV)-Specific humoral and cellular immune responses following VSV-Ebola virus vaccination in humans","volume":"219","author":"Poetsch","year":"2019","journal-title":"J\u00a0Infect Dis"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105647_bib88","doi-asserted-by":"crossref","first-page":"7666","DOI":"10.1038\/s41467-024-51453-z","article-title":"Long-term cellular immunity of vaccines for Zaire Ebola virus diseases","volume":"15","author":"Wiedemann","year":"2024","journal-title":"Nat Commun"},{"issue":"46","key":"10.1016\/j.ebiom.2025.105647_bib89","doi-asserted-by":"crossref","first-page":"6599","DOI":"10.1016\/j.vaccine.2022.09.037","article-title":"Immunogenicity of rVSVDeltaG-ZEBOV-GP Ebola vaccine (ERVEBO(R)) in African clinical trial participants by age, sex, and baseline GP-ELISA titer: a post hoc analysis of three Phase 2\/3 trials","volume":"40","author":"Simon","year":"2022","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.ebiom.2025.105647_bib90","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1038\/s41591-019-0602-4","article-title":"Polyclonal and convergent antibody response to Ebola virus vaccine rVSV-ZEBOV","volume":"25","author":"Ehrhardt","year":"2019","journal-title":"Nat Med"},{"issue":"9","key":"10.1016\/j.ebiom.2025.105647_bib91","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.vaccine.2016.11.083","article-title":"Comparison of platform technologies for assaying antibody to Ebola virus","volume":"35","author":"Wilkinson","year":"2017","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.ebiom.2025.105647_bib92","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S1473-3099(17)30313-4","article-title":"Safety and immunogenicity of the rVSV\u0394G-ZEBOV-GP Ebola virus vaccine candidate in healthy adults: a phase 1b randomised, multicentre, double-blind, placebo-controlled, dose-response study","volume":"17","author":"Heppner","year":"2017","journal-title":"Lancet Infect Dis"},{"issue":"7","key":"10.1016\/j.ebiom.2025.105647_bib93","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1093\/infdis\/jiz241","article-title":"Immunogenicity, Lot consistency, and extended safety of rVSVDeltaG-ZEBOV-GP vaccine: a phase 3 randomized, double-blind, placebo-controlled study in healthy adults","volume":"220","author":"Halperin","year":"2019","journal-title":"J\u00a0Infect Dis"},{"issue":"17","key":"10.1016\/j.ebiom.2025.105647_bib94","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1056\/NEJMoa1502924","article-title":"Phase 1 trials of rVSV Ebola vaccine in Africa and Europe","volume":"374","author":"Agnandji","year":"2016","journal-title":"New England J Med"},{"issue":"2","key":"10.1016\/j.ebiom.2025.105647_bib95","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1128\/iai.44.2.528-533.1984","article-title":"Passive antibody therapy of Lassa fever in cynomolgus monkeys: importance of neutralizing antibody and Lassa virus strain","volume":"44","author":"Jahrling","year":"1984","journal-title":"Infect Immun"},{"key":"10.1016\/j.ebiom.2025.105647_bib96","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.antiviral.2016.08.012","article-title":"Treatment of Lassa virus infection in outbred Guinea pigs with first-in-class human monoclonal antibodies","volume":"133","author":"Cross","year":"2016","journal-title":"Antiviral Res"},{"issue":"12","key":"10.1016\/j.ebiom.2025.105647_bib97","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1016\/j.chom.2022.10.018","article-title":"Lassa virus glycoprotein nanoparticles elicit neutralizing antibody responses and protection","volume":"30","author":"Brouwer","year":"2022","journal-title":"Cell Host Microbe"},{"issue":"597","key":"10.1016\/j.ebiom.2025.105647_bib98","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abf6348","article-title":"A\u00a0single-shot Lassa vaccine induces long-term immunity and protects cynomolgus monkeys against heterologous strains","volume":"13","author":"Mateo","year":"2021","journal-title":"Sci Transl Med"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105647_bib99","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41541-020-00219-x","article-title":"Adjuvant formulated virus-like particles expressing native-like forms of the Lassa virus envelope surface glycoprotein are immunogenic and induce antibodies with broadly neutralizing activity","volume":"5","author":"Muller","year":"2020","journal-title":"NPJ Vaccines"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105647_bib100","doi-asserted-by":"crossref","first-page":"4223","DOI":"10.1038\/s41467-018-06741-w","article-title":"Non-neutralizing antibodies elicited by recombinant Lassa-Rabies vaccine are critical for protection against Lassa fever","volume":"9","author":"Abreu-Mota","year":"2018","journal-title":"Nat Commun"},{"issue":"6249","key":"10.1016\/j.ebiom.2025.105647_bib101","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1126\/science.aab3920","article-title":"EBOLA VACCINE. VSV-EBOV rapidly protects macaques against infection with the 2014\/15 Ebola virus outbreak strain","volume":"349","author":"Marzi","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.ebiom.2025.105647_bib102","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41541-019-0104-x","article-title":"A\u00a0recombinant vesicular stomatitis-based Lassa fever vaccine elicits rapid and long-term protection from lethal Lassa virus infection in Guinea pigs","volume":"4","author":"Stein","year":"2019","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.ebiom.2025.105647_bib103","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.774026","article-title":"Single dose of a VSV-based vaccine rapidly protects macaques from Marburg virus disease","volume":"12","author":"Marzi","year":"2021","journal-title":"Front Immunol"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S235239642500091X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S235239642500091X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T16:18:49Z","timestamp":1762618729000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S235239642500091X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":103,"alternative-id":["S235239642500091X"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2025.105647","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preclinical development of a replication-competent vesicular stomatitis virus-based Lassa virus vaccine candidate advanced into human clinical trials","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2025.105647","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105647"}}